HK1142323A1 - 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors - Google Patents

6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors

Info

Publication number
HK1142323A1
HK1142323A1 HK10108808.3A HK10108808A HK1142323A1 HK 1142323 A1 HK1142323 A1 HK 1142323A1 HK 10108808 A HK10108808 A HK 10108808A HK 1142323 A1 HK1142323 A1 HK 1142323A1
Authority
HK
Hong Kong
Prior art keywords
imidazo
pyridine
phenyl
carbonitrile derivatives
cathepsin inhibitors
Prior art date
Application number
HK10108808.3A
Other languages
English (en)
Inventor
Jiaqiang Cai
Zoran Rankovic
Philip Stephen Jones
David Jonathan Bennett
Xavier Fradera
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1142323A1 publication Critical patent/HK1142323A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK10108808.3A 2007-07-16 2010-09-16 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors HK1142323A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07112517 2007-07-16
PCT/EP2008/059172 WO2009010491A1 (fr) 2007-07-16 2008-07-14 Dérivés de 6-phényl-1h-imidazo[4,5-c]pyridine-4-carbonitrile comme inhibiteur de la cathepsine

Publications (1)

Publication Number Publication Date
HK1142323A1 true HK1142323A1 (en) 2010-12-03

Family

ID=38846911

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10108808.3A HK1142323A1 (en) 2007-07-16 2010-09-16 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors

Country Status (20)

Country Link
EP (1) EP2178873B1 (fr)
JP (1) JP5371976B2 (fr)
KR (1) KR20100043235A (fr)
CN (1) CN101842373B (fr)
AR (1) AR067530A1 (fr)
AT (1) ATE492546T1 (fr)
AU (1) AU2008277679B2 (fr)
BR (1) BRPI0813587A2 (fr)
CA (1) CA2693887A1 (fr)
CL (1) CL2008002082A1 (fr)
DE (1) DE602008004167D1 (fr)
EC (1) ECSP109966A (fr)
ES (1) ES2356279T3 (fr)
HK (1) HK1142323A1 (fr)
IL (1) IL202769A0 (fr)
PE (1) PE20091087A1 (fr)
RU (1) RU2485119C2 (fr)
TW (1) TW200911803A (fr)
WO (1) WO2009010491A1 (fr)
ZA (1) ZA200909132B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932251B2 (en) 2007-07-16 2011-04-26 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
US8026236B2 (en) 2009-01-16 2011-09-27 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
TW201035094A (en) * 2009-01-16 2010-10-01 Organon Nv 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
US9115126B2 (en) 2010-01-15 2015-08-25 Merck Sharp & Dohme B.V. 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives
WO2013018733A1 (fr) 2011-07-29 2013-02-07 富士フイルム株式会社 Dérivé de 1,5-naphtyridine ou sel de celui-ci
PL2840083T3 (pl) 2012-04-17 2018-01-31 Astellas Pharma Inc Bicykliczny aromatyczny związek heterocykliczny zawierający azot
WO2020201572A1 (fr) 2019-04-05 2020-10-08 Université De Bretagne Occidentale Inhibiteurs du récepteur 2 activé par une protéase pour le traitement d'une neuropathie sensorielle induite par une intoxication neurotoxique marine
TW202140002A (zh) 2020-01-20 2021-11-01 美商健臻公司 用於復發型多發性硬化症的治療性酪胺酸激酶抑制劑
EP3858471A1 (fr) 2020-01-31 2021-08-04 Novamem AG Production sans solvant de structures polymères poreuses
CA3201936A1 (fr) 2020-12-10 2022-06-16 Minhua Chen Forme cristalline de tolebrutinib et methode de preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62972C2 (en) * 1997-07-03 2004-01-15 Application of imidazopyrimidins and imidazopyridins for the treatment of neural disorders
GB9921150D0 (en) * 1999-09-07 1999-11-10 Merck Sharp & Dohme Therapeutic agents
PA8535601A1 (es) * 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
GB0121033D0 (en) * 2001-08-30 2001-10-24 Novartis Ag Organic compounds
SE0201980D0 (sv) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
FR2852957B1 (fr) * 2003-03-31 2005-06-10 Sod Conseils Rech Applic Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
WO2005085210A1 (fr) * 2004-03-10 2005-09-15 Ono Pharmaceutical Co., Ltd. Nitriles et compositions médicinales contenant ceux-ci en tant qu'ingrédient actif
TW200734338A (en) * 2006-01-16 2007-09-16 Organon Nv 6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives

Also Published As

Publication number Publication date
EP2178873A1 (fr) 2010-04-28
ES2356279T3 (es) 2011-04-06
CL2008002082A1 (es) 2009-01-02
ECSP109966A (es) 2010-03-31
DE602008004167D1 (en) 2011-02-03
AU2008277679B2 (en) 2012-11-15
PE20091087A1 (es) 2009-07-20
IL202769A0 (en) 2010-06-30
WO2009010491A1 (fr) 2009-01-22
AR067530A1 (es) 2009-10-14
KR20100043235A (ko) 2010-04-28
AU2008277679A1 (en) 2009-01-22
RU2010105234A (ru) 2011-08-27
CA2693887A1 (fr) 2009-01-22
EP2178873B1 (fr) 2010-12-22
CN101842373B (zh) 2013-12-18
ZA200909132B (en) 2010-08-25
ATE492546T1 (de) 2011-01-15
JP5371976B2 (ja) 2013-12-18
TW200911803A (en) 2009-03-16
JP2010533675A (ja) 2010-10-28
CN101842373A (zh) 2010-09-22
RU2485119C2 (ru) 2013-06-20
BRPI0813587A2 (pt) 2014-12-30

Similar Documents

Publication Publication Date Title
HK1142323A1 (en) 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
PL2094263T3 (pl) Pochodne 2-adamantylo-butyroamidowe jako selektywne inhibitory 11beta-HSD1
IL211148A0 (en) 3h-imidazo [4,5-c] pyridine-6-carboxamides as anti-inflammatory agents
HK1138589A1 (en) Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors
HK1135976A1 (en) Pyridin-3-yl derivatives as immunomodulating agents
HK1105592A1 (en) Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors
HK1133654A1 (en) Pyridin-4-yl derivatives as immunomodulating agents
HK1107348A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
EP2217590A4 (fr) Dérivés de pyridopyrimidine en tant qu'inhibiteurs de kinase p13
IL198462A0 (en) Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors
ZA200809800B (en) 2-Thioxanthine derivatives acting as Mpo-inhibitors
HK1115321A1 (en) Camptothecin derivatives as chemoradiosensitizing agents
ZA200805566B (en) 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors
IL195915A0 (en) 3-amino -imidazo[1,2-a]pyridine derivatives as sglt inhibitors
ZA200901128B (en) Spirocyclic azaindole derivatives
IL205508A0 (en) 7 - azaindole derivatives as selective 11 - beta - hydroxysteroid dehydrogenase type 1 inhibitors
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
ZA200903175B (en) Spiro-piperidine derivatives
TWI339663B (en) Spiro-piperidine derivatives
IL194873A0 (en) Methods for reducing 7/9-nitrotetracycline derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150714